Lamivudine recalls
The FDA has published 3 recalls involving Lamivudine since 2015. The latest was reported on 18 Sep 2019. Most were for potency & assay. American Health Packaging has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2015
Last 12 months0reported
Class I00% of total
Ongoing0latest 18 Sep 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 33%Class III 2 67%
Why lamivudine is recalled
Companies
By year
All lamivudine recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Lamivudine Tablets, USP, 150 mg Unit Dose Blisters recalled | American Health Packaging | Packaging Defects | Nationwide |
| Drug | CLASS III | Lamivudine Oral Solution, USP, 10 mg recalled by Silarx Pharmaceutical | Silarx Pharmaceutical | Other | Nationwide |
| Drug | CLASS II | Lamivudine and Zidovudine Tablets USP 150mg/300mg Dose Blisters recalled | American Health Packaging | Potency & Assay | Nationwide |
Should you stop taking Lamivudine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.